Quantcast

Latest fibrosis Stories

2011-10-24 09:10:05

NIH stops one treatment arm of trial; Other two treatments to continue The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had...

2011-10-16 21:29:56

Diagnostic tool for distinguishing intestinal inflammation from fibrosis could allow doctors to deliver efficient, timely treatment It's difficult for doctors to tell whether a patient with Crohn's disease has intestinal fibrosis, which requires surgery, or inflammation, which can be treated with medicine. A new imaging method might make that task easier, according to a U-M-led study. Ultrasound elasticity imaging, or UEI, could allow doctors to noninvasively make the distinction...

2011-10-12 13:28:20

New research in The FASEB Journal suggests that cigarette smoke interferes with the Cystic Fibrosis Transmembrane Conductance Regulator protein, leading to dry, sticky mucus and increased infections If you smoke cigarettes, you have more in common with someone who has cystic fibrosis than you think. A new research report appearing online in the FASEB Journal (http://www.fasebj.org) shows that smoking cigarettes affects the lungs in a way that is very similar to cystic fibrosis, a life...

2011-10-10 07:00:00

Agile Sciences will collaborate with Dr. Richard Boucher, Director of the Cystic Fibrosis Center at the University of North Carolina, Chapel Hill Raleigh, NC (PRWEB) October 10, 2011 The National Institutes of Health (NIH) has awarded Agile Sciences a Phase I STTR Grant to evaluate the efficacy of Agile Sciencesâ proprietary Agilyteâ“ž¢ anti-biofilm molecules for treating lung infections of cystic fibrosis patients. The molecules will be tested in...

2011-10-06 09:18:01

Study points to a phosphorylation pathway that may contribute to the development of lung injury and fibrosis A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin. Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related